| Term 
 
        | Targeted cancer therapies |  | Definition 
 
        | -block cell signals --> apoptosis (programmed cell death) -may be used as single agent or combined w/ other chemotherapies -expensive Example: VEGF - vascular endothelial growth factor |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -topoisomerase II inhibitor -treat testicular cancer & small cell lung cancer -IV -SE: n/v/d, anorexia, stomatitis, rash, chills -Adverse: bronchospasm, bone marrow suppression, anaphylaxis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -topoisomerase I inhibitor -treat advanced colon cancer -IV |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -tyrosine kinase inhibitor -treat refractory non-small cell lung cancer -po -SE: HTN, pruritis, pustular rash, conjunctivitis, corneal erosions, hemoptysis, gi hemorrhage drug-drug: warfarin, azoles, erythromycin, St. John's wort (inactivates drug), anticonvulsants -watch CYP 34A enzyme (can inhibit or stimulate) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -tyrosine kinase inhibitor -treat chronic myeloid leukemia, GIST (GI stromal tumors) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -proteasome inhibitor -treat refractory multiple myeloma, under investigation for other therapies -IVP for 3-5 seconds -SE: fatigue, dizziness, hypotension, n/v/d, peripheral neuropathies, pyrexia, neutropenia, thrombocytopenia |  | 
        |  | 
        
        | Term 
 
        | Multikinase inhibitors (MKI's) |  | Definition 
 
        | -newest classification of targeted therapies for cancer |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -inhibit formation of blood vessels needed for tumor growth & metastasis -treat metastatic carcinoma of colon & rectum -Example: Bevacizumab (Avastin) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -angiogenesis inhibitor -targets VEGF (vascular endothelial growth factor) -IV SE: dizziness, diarrhea, epistaxis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -block growth of tumor cells or alert immune system to attack cancer cells Examples: cetuximab (Erbitux), trastuzumab (Herceptin), panitumumab (Vectibix), rituximab (Rituxan) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -monoclonal antibody drug -treat B-cell non-Hodgkin's; single agent or in combination -IV -SE: n/v, vertigo, h/a, fever, chills, fatigue -Adverse: mucotaneous, dysrhythmias, renal failure, bone marrow suppression -monitor CBC |  | 
        |  | 
        
        | Term 
 
        | Nursing measures for monoclonal antibody drugs |  | Definition 
 
        | -monitor CBC, LFT. renal, electrolytes -assess stomatitis -assess neuropathies (stocking/glove syndrome) -oral care -monitor weight, I&O, VS, temp -small, frequent meals -bland foods (BRAT diet), no caffeine/carbonation -psychosocial issues - alopecia -monitor for infection (medical asepsis) -assess IV site for infiltrate/extravastion/necrosis |  | 
        |  |